Esfandiary M, Khosravi A, Asadi S, Nikaein D, Hassan J, Sharifzadeh A
BMC Microbiol. 2024; 24(1):154.
PMID: 38704559
PMC: 11069153.
DOI: 10.1186/s12866-024-03305-5.
Agarwal R, Agarwal R, Chen X, Lua J, Ang J
Glob Pediatr Health. 2017; 4:2333794X17696684.
PMID: 28491922
PMC: 5406153.
DOI: 10.1177/2333794X17696684.
Zhao Q, Chen Y, Wang Y, Xu D
Zhongguo Dang Dai Er Ke Za Zhi. 2016; 18(4):311-5.
PMID: 27097574
PMC: 7390069.
Alphonsa B, Sudheesh Kumar P, Praveen G, Biswas R, Chennazhi K, Jayakumar R
Pharm Res. 2013; 31(5):1338-51.
PMID: 24287625
DOI: 10.1007/s11095-013-1254-6.
Chang Y, Choi I, Shin W, Lee J, Kim Y, Park M
Korean J Pediatr. 2013; 56(2):68-74.
PMID: 23482686
PMC: 3589593.
DOI: 10.3345/kjp.2013.56.2.68.
A murine model for disseminated candidiasis in neonates.
Tsai N, Laforce-Nesbitt S, Tucker R, Bliss J
Pediatr Res. 2010; 69(3):189-93.
PMID: 21099449
PMC: 3076736.
DOI: 10.1203/PDR.0b013e318206fd3e.
Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship.
Patel S, Saiman L
Clin Perinatol. 2010; 37(3):547-63.
PMID: 20813270
PMC: 4440667.
DOI: 10.1016/j.clp.2010.06.004.
Candida infections of the genitourinary tract.
Achkar J, Fries B
Clin Microbiol Rev. 2010; 23(2):253-73.
PMID: 20375352
PMC: 2863365.
DOI: 10.1128/CMR.00076-09.
Antifungal activity of 25-azalanosterol against Candida species.
Wang J, Wu J
Eur J Clin Microbiol Infect Dis. 2008; 27(11):1131-6.
PMID: 18574605
DOI: 10.1007/s10096-008-0554-y.
[Recommendation for the prevention of nosocomial infections in neonatal intensive care patients with a birth weight less than 1,500 g. Report by the Committee of Hospital Hygiene and Infection Prevention of the Robert Koch Institute].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007; 50(10):1265-303.
PMID: 18041117
PMC: 7080031.
Antifungal agents in neonates: issues and recommendations.
Almirante B, Rodriguez D
Paediatr Drugs. 2007; 9(5):311-21.
PMID: 17927303
DOI: 10.2165/00148581-200709050-00004.
Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth.
Venkatesh M, Pham D, Fein M, Kong L, Weisman L
Antimicrob Agents Chemother. 2007; 51(4):1240-5.
PMID: 17261622
PMC: 1855490.
DOI: 10.1128/AAC.01298-06.
A glucose sensor in Candida albicans.
Brown V, Sexton J, Johnston M
Eukaryot Cell. 2006; 5(10):1726-37.
PMID: 17030998
PMC: 1595344.
DOI: 10.1128/EC.00186-06.
Is routine fluconazole prophylaxis necessary in preterm infants?.
Morales-Molina J, Mateu-de Antonio J, Grau S, Luque S, Berenguer N
Pharm World Sci. 2006; 28(3):163-4.
PMID: 17004020
DOI: 10.1007/s11096-006-9025-7.
Use of prophylactic fluconazole in a neonatal intensive care unit: efficacy is similar to that described in adult high-risk surgical patients.
Manzoni P, Farina D, Leonessa M, Priolo C, Gomirato G
Crit Care. 2006; 10(1):402.
PMID: 16420658
PMC: 1550841.
DOI: 10.1186/cc3958.
